Study finds Pfizer’s antiviral has little or even zero benef

Study finds Pfizer's antiviral has little or even zero benefit for younger adults, and WHO says BA.5 omicron subvariant accounted for 74% of cases in latest week

https://www.marketwatch.com/story/study-finds-pfizers-antiviral-has-little-or-zero-benefit-for-younger-adults-and-who-says-ba-5-omicron-subvariant-accounted-for-74-of-cases-in-latest-week-11661438030?itm_source=parsely-api&mod=mw_pushly&send_date=20220826?